TEACHERS ADVISORS, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 144 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$5,283,000
+53.0%
78,335
+4.6%
0.01%
+20.0%
Q4 2018$3,454,000
-70.0%
74,907
-49.9%
0.01%
-28.6%
Q3 2018$11,530,000
+80.8%
149,518
+97.5%
0.01%
-12.5%
Q2 2018$6,376,000
+7.9%
75,695
+4.8%
0.01%0.0%
Q1 2018$5,909,000
+92.9%
72,256
+34.8%
0.01%
+100.0%
Q4 2017$3,064,000
-2.8%
53,591
+13.5%
0.00%0.0%
Q3 2017$3,152,000
+31.1%
47,216
+1.0%
0.00%
+33.3%
Q2 2017$2,404,000
+36.0%
46,733
+54.4%
0.00%0.0%
Q1 2017$1,767,000
+43.1%
30,258
+2.3%
0.00%
+50.0%
Q4 2016$1,235,000
-3.1%
29,592
+22.7%
0.00%0.0%
Q3 2016$1,274,000
+31.2%
24,125
+4.0%
0.00%0.0%
Q2 2016$971,000
+23.9%
23,186
+20.1%
0.00%
+100.0%
Q1 2016$784,000
-37.4%
19,3000.0%0.00%
-50.0%
Q4 2015$1,253,000
-6.4%
19,300
+1.8%
0.00%
-33.3%
Q3 2015$1,338,000
-33.8%
18,955
+4.2%
0.00%
-25.0%
Q2 2015$2,021,000
-5.6%
18,185
-19.9%
0.00%0.0%
Q1 2015$2,140,000
-3.9%
22,697
+14.2%
0.00%0.0%
Q4 2014$2,227,000
+91.3%
19,877
+4.7%
0.00%
+100.0%
Q3 2014$1,164,000
+33.8%
18,9770.0%0.00%0.0%
Q2 2014$870,000
+133.2%
18,977
+99.3%
0.00%
+100.0%
Q1 2014$373,000
+63.6%
9,5200.0%0.00%0.0%
Q4 2013$228,000
-14.3%
9,5200.0%0.00%0.0%
Q3 2013$266,0009,5200.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders